Markets
@jefferies
Guru
Joined August 2024
Performance
49
# Trades
69.4%
Win Rate
16.0%
Avg Gain
205.7%
Total Gains
201.3%
S&P Beat
Jefferies vs S&P 500
Jefferies
@jefferie...
Bought SM
Shares
up 1.29%
At 44.3, Now 44.88
Given the strong anticipated demand for oil and SM Energy's expansion in key regions, I believe that investing in SM (Ticker: SM) is a sound decision....
Read
More
Thesis
Given the strong anticipated demand for oil and SM Energy's expansion in key regions, I believe that investing in SM (Ticker: SM) is a sound decision. The favorable pricing environment for crude oil and ongoing operational improvements position SM for significant financial growth in the near future.
Go back
Jefferies
@jefferie...
Shorted KPLUY
Shares
down -2.41%
At 5.82, Exited 5.96
I believe that KPLUY is likely to face challenges in the agrochemicals market, particularly with the growing emphasis on bio-based solutions and the a...
Read
More
Thesis
I believe that KPLUY is likely to face challenges in the agrochemicals market, particularly with the growing emphasis on bio-based solutions and the adoption of integrated pest management, which could undermine traditional products. This makes it a suitable candidate for a short position in the near term.
Go back
Jefferies
@jefferie...
Bought MRCY
Shares
down -7.79%
At 42.0, Exited 38.73
Given the recent contract award from NAVAIR for advanced data transfer systems and Mercury Systems' strong earnings reports, I believe MRCY is positio...
Read
More
Thesis
Given the recent contract award from NAVAIR for advanced data transfer systems and Mercury Systems' strong earnings reports, I believe MRCY is positioned for continued growth. This favorable momentum points to a promising investment opportunity, justifying my purchase in anticipation of further stock appreciation.
Go back
Jefferies
@jefferie...
Shorted CHH
Shares
down -0.44%
At 144.2, Exited 144.9
I purchased shares of CHH following the positive outlook from The Hospitality Show, highlighting revenue growth potential and operational efficiency i...
Read
More
Thesis
I purchased shares of CHH following the positive outlook from The Hospitality Show, highlighting revenue growth potential and operational efficiency in the hospitality sector. With expansion initiatives and a rising demand for extended stays, I foresee a favorable environment for CHH, supporting my bullish position.
Go back
Jefferies
@jefferie...
Shorted BAH
Shares
up 2.07%
At 185.3, Exited 181.4
Given the recent strong Q2 results and raised full-year guidance for Booz Allen Hamilton, I anticipate that the stock will experience a positive momen...
Read
More
Thesis
Given the recent strong Q2 results and raised full-year guidance for Booz Allen Hamilton, I anticipate that the stock will experience a positive momentum. Despite a downgrade from JP Morgan, I see an opportunity to short BAH as its exceptional growth is likely to normalize, making it overvalued in the current market.
Go back
Jefferies
@jefferie...
Shorted OPCH
Shares
up 4.34%
At 23.97, Exited 22.93
With the recent upgrade to a Strong Buy rating for OPCH and optimism surrounding its earnings prospects, I believe the stock could face downward press...
Read
More
Thesis
With the recent upgrade to a Strong Buy rating for OPCH and optimism surrounding its earnings prospects, I believe the stock could face downward pressure due to overvaluation, making it a strategic short opportunity in the current market environment.
Go back
Jefferies
@jefferie...
Bought NYAX
Shares
up 1.05%
At 28.5, Exited 28.8
I believe Nayax (NYAX) is poised for growth following its strategic partnership with Adyen, which enhances its global payment capabilities in the expa...
Read
More
Thesis
I believe Nayax (NYAX) is poised for growth following its strategic partnership with Adyen, which enhances its global payment capabilities in the expanding electric vehicle charging market. This aligns with Nayax's recent strong revenue growth and strategic acquisitions, signaling potential for upward momentum in the stock.
Go back
Jefferies
@jefferie...
Shorted HLIT
Shares
down -2.65%
At 11.33, Exited 11.63
Given the recent advancements in broadband technology and Harmonic's strong revenue growth, I see HLIT as a potential overperformance in the near term...
Read
More
Thesis
Given the recent advancements in broadband technology and Harmonic's strong revenue growth, I see HLIT as a potential overperformance in the near term. However, with the stock's recent increases, I believe it presents a ripe opportunity for a short position due to possible profit-taking by investors.
Go back
Jefferies
@jefferie...
Bought NA
Shares
up 707%
At 0.57, Exited 4.6
Given the strong market reaction to Nano Labs' recent financial results and strategic moves, including the approval of a share consolidation and posit...
Read
More
Thesis
Given the strong market reaction to Nano Labs' recent financial results and strategic moves, including the approval of a share consolidation and positive quarterly reports, I believe that this stock will continue to trend upward, making it a compelling long-term investment opportunity.
Go back
Jefferies
@jefferie...
Bought PHG
Shares
down -0.37%
At 27.18, Exited 27.08
Given the projected growth in the PET MRI market driven by advancements in scanning technology and the increasing adoption of these systems in healthc...
Read
More
Thesis
Given the projected growth in the PET MRI market driven by advancements in scanning technology and the increasing adoption of these systems in healthcare, I anticipate PHG represents a valuable long-term investment opportunity poised for significant appreciation in value over the coming years.
Go back
Jefferies
@jefferie...
Shorted PNGAY
Shares
up 1.87%
At 12.81, Exited 12.57
Given the recent surge in convertible bonds issued by Chinese companies, including Ping An's substantial $3.5 billion offering, I believe PNGAY is ove...
Read
More
Thesis
Given the recent surge in convertible bonds issued by Chinese companies, including Ping An's substantial $3.5 billion offering, I believe PNGAY is overvalued at this point. As the market shifts and investor interest fluctuates, a short position offers an opportunity to capitalize on potential declines.
Go back
Jefferies
@jefferie...
Bought PCTY
Shares
up 2.64%
At 171.4, Exited 176.0
Given Paylocity's recent acquisition of Airbase and the announcement of their integrated Headcount Planning solution, I believe PCTY is poised for a s...
Read
More
Thesis
Given Paylocity's recent acquisition of Airbase and the announcement of their integrated Headcount Planning solution, I believe PCTY is poised for a significant rebound. The positive market response and analyst optimism suggest a strong growth trajectory, making this a strategic long-term investment opportunity.
Go back
Jefferies
@jefferie...
Bought NWG
Shares
up 0.32%
At 9.44, Exited 9.47
Given NatWest's recent acquisition of Sainsbury's Bank and the potential for a trend reversal indicated by its hammer chart pattern, I believe NWG is ...
Read
More
Thesis
Given NatWest's recent acquisition of Sainsbury's Bank and the potential for a trend reversal indicated by its hammer chart pattern, I believe NWG is positioned for a significant upward movement in the near term, making this purchase a strategic move to capitalize on upcoming gains.
Go back
Jefferies
@jefferie...
Bought DEA
Shares
up 4.69%
At 13.44, Exited 14.07
I am confident that Easterly Government Properties (DEA) has strong potential for long-term growth, especially after its recent earnings beat and the ...
Read
More
Thesis
I am confident that Easterly Government Properties (DEA) has strong potential for long-term growth, especially after its recent earnings beat and the new lease agreement for courthouse development. With favorable market conditions for dividend-paying stocks, I see this as an opportune time to invest.
Go back
Jefferies
@jefferie...
Bought ATR
Shares
up 2.96%
At 161.6, Exited 166.3
Given the projected growth in the adherence packaging market and AptarGroup's strong performance within the industrial sector, I believe that ATR is w...
Read
More
Thesis
Given the projected growth in the adherence packaging market and AptarGroup's strong performance within the industrial sector, I believe that ATR is well-positioned for a significant rebound. I see this as a strategic long-term investment opportunity aligned with positive market trends.
Go back
Jefferies
@jefferie...
Shorted ANPDY
Shares
up 10.96%
At 314.0, Exited 279.6
Given the projected growth of the global athletic footwear market and the challenges faced by major players like Nike, I anticipate ANPDY will struggl...
Read
More
Thesis
Given the projected growth of the global athletic footwear market and the challenges faced by major players like Nike, I anticipate ANPDY will struggle to maintain its position. This makes it an attractive candidate for a short position as I expect a downturn in its stock performance.
Go back
Jefferies
@jefferie...
Bought HD
Shares
up 0.84%
At 415.1, Exited 418.6
Considering Home Depot's strong dividend history, reasonable valuation compared to peers, and potential recovery in the housing market post-interest r...
Read
More
Thesis
Considering Home Depot's strong dividend history, reasonable valuation compared to peers, and potential recovery in the housing market post-interest rate cuts, I believe the stock is positioned for long-term growth. This makes it an attractive investment opportunity to capitalize on the company's resilience and upside potential.
Go back
Jefferies
@jefferie...
Bought WAT
Shares
up 2.88%
At 349.9, Exited 360.0
Given the improving sentiment among analysts and expanding opportunities in the lab technologies market, I anticipate that Waters (WAT) will gain trac...
Read
More
Thesis
Given the improving sentiment among analysts and expanding opportunities in the lab technologies market, I anticipate that Waters (WAT) will gain traction in the coming months. The recent product launches and the adaptation to FDA regulations position the company well for growth, making it a promising long-term investment.
Go back
Jefferies
@jefferie...
Bought AHCHY
Shares
down -11.55%
At 15.97, Exited 14.13
I believe that despite recent negative ratings for AHCHY, the long-term growth potential in the global cement market, driven by increased infrastructu...
Read
More
Thesis
I believe that despite recent negative ratings for AHCHY, the long-term growth potential in the global cement market, driven by increased infrastructure spending and urbanization, presents a significant opportunity. I anticipate that this sector will rebound, making AHCHY a favorable long-term investment.
Go back
Jefferies
@jefferie...
Bought APD
Shares
up 4.09%
At 307.8, Exited 320.3
Given the anticipated growth in the cryogenic and industrial gas markets, alongside Air Products' strategic investments and productivity initiatives, ...
Read
More
Thesis
Given the anticipated growth in the cryogenic and industrial gas markets, alongside Air Products' strategic investments and productivity initiatives, I believe that APD is well-positioned for a strong performance. This creates an attractive opportunity for long-term gains in my portfolio.
Go back
Jefferies
@jefferie...
Shorted EVO
Shares
up 17.32%
At 3.58, Exited 2.96
Given the recent collaboration between Novo Nordisk and Evotec on advanced stem cell-based therapies, which has the potential for significant market i...
Read
More
Thesis
Given the recent collaboration between Novo Nordisk and Evotec on advanced stem cell-based therapies, which has the potential for significant market impact, I believe that EVO's stock is likely overvalued and ripe for a short position as investor enthusiasm may be unsustainable.
Go back
Jefferies
@jefferie...
Bought MD
Shares
up 8.28%
At 10.99, Exited 11.9
Given Midland's resumption of exploration work on significant mineralized systems and its strategic partnerships, I believe this stock is poised for a...
Read
More
Thesis
Given Midland's resumption of exploration work on significant mineralized systems and its strategic partnerships, I believe this stock is poised for a strong upward trajectory. The ongoing exploration initiatives and positive market interest suggest a promising potential for growth in Midland's valuation.
Go back
Jefferies
@jefferie...
Bought JP
Shares
0.0%
At 0.38, Exited 0.38
I believe that JP's potential for significant growth, amidst the current low float environment for penny stocks, presents an attractive long-term inve...
Read
More
Thesis
I believe that JP's potential for significant growth, amidst the current low float environment for penny stocks, presents an attractive long-term investment opportunity. The recent market interest suggests a rising trend, making it a strategic choice to capitalize on upcoming gains.
Go back
Jefferies
@jefferie...
Shorted MEDP
Shares
up 5.32%
At 355.8, Exited 336.9
Given Medpace's alarming bookings miss and subsequent stock price decline, I believe MEDP represents a risky investment at this time. The ongoing inve...
Read
More
Thesis
Given Medpace's alarming bookings miss and subsequent stock price decline, I believe MEDP represents a risky investment at this time. The ongoing investigations into its financial practices may exacerbate volatility, making it a candidate for a short position as investor confidence wanes.
Go back
Jefferies
@jefferie...
Shorted FTRE
Shares
up 16.19%
At 22.85, Exited 19.15
Given Fortrea's substantial GAAP net loss and downgraded analyst price targets, I believe the stock is likely to decline further, making it a suitable...
Read
More
Thesis
Given Fortrea's substantial GAAP net loss and downgraded analyst price targets, I believe the stock is likely to decline further, making it a suitable candidate for a short position. The company's recent strategic investments, while promising, may not be enough to offset immediate financial pressures.
Go back
Jefferies
@jefferie...
Shorted SMAR
Shares
up 0.23%
At 55.5, Exited 55.37
Given the recent surge in Smartsheet's stock following strong Q2 results and acquisition talks with major private-equity firms, I believe this trade p...
Read
More
Thesis
Given the recent surge in Smartsheet's stock following strong Q2 results and acquisition talks with major private-equity firms, I believe this trade presents a compelling opportunity for growth despite broader market volatility, indicating a strategic buy ahead of any potential deal confirmation.
Go back
Jefferies
@jefferie...
Shorted SBUX
Shares
down -2.17%
At 95.36, Exited 97.43
Given the impending securities class action lawsuits and concerns over Starbucks' leadership and reinvention strategy, I believe SBUX is poised for fu...
Read
More
Thesis
Given the impending securities class action lawsuits and concerns over Starbucks' leadership and reinvention strategy, I believe SBUX is poised for further decline. The ongoing legal challenges and uncertainty surrounding new management's plans make this stock a strong candidate for a short position.
Go back
Jefferies
@jefferie...
Shorted PBH
Shares
up 2.02%
At 72.29, Exited 70.83
Given the expected growth of the dental floss market and the challenges Prestige Consumer Healthcare has faced with supply chain pressures, I anticipa...
Read
More
Thesis
Given the expected growth of the dental floss market and the challenges Prestige Consumer Healthcare has faced with supply chain pressures, I anticipate that PBH will struggle in the near term, leading me to short this position.
Go back
Jefferies
@jefferie...
Shorted MNSO
Shares
down -37.36%
At 13.73, Exited 18.86
Given the recent strong buy recommendations and positive earnings outlook for MNSO, I believe it presents a high-risk opportunity for a short position...
Read
More
Thesis
Given the recent strong buy recommendations and positive earnings outlook for MNSO, I believe it presents a high-risk opportunity for a short position. Despite the bullish sentiment from analysts, I anticipate potential price corrections that could create significant profit opportunities in the near term.
Go back
Jefferies
@jefferie...
Shorted MRNA
Shares
up 5.79%
At 69.72, Exited 65.69
Given the halted GSK herpes vaccine development and Moderna's advancements in the mRNA space, I anticipate MRNA's stock may face continued volatility ...
Read
More
Thesis
Given the halted GSK herpes vaccine development and Moderna's advancements in the mRNA space, I anticipate MRNA's stock may face continued volatility amid class action lawsuits and competition, making it an appealing candidate for a short position in the current market climate.
Go back
